Patents by Inventor James Matz

James Matz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170217149
    Abstract: A negative-working infrared radiation-sensitive lithographic printing plate precursor can be imaged and developed on-press to provide a lithographic printing plate. Such precursor has an initiator composition that contains compound A of Structure (I) and one or more compounds collectively as compound B of Structure (II) or Structure (III): wherein R1, R2, R3, R4, R5 and R6 are independently alkyl or alkoxy groups each having 2 to 9 carbon atoms; at least one of R3 and R4 is different from R1 or R2; the difference of total number of carbon atoms in R1 and R2 and the total number of carbon atoms in R3 and R4 is 0 to 4; the difference of total number of carbon atoms in R1 and R2 and the total number of carbon atoms in R5 and R6 is 0 to 4; and X1, X2 and X3 are the same or different anions.
    Type: Application
    Filed: April 1, 2016
    Publication date: August 3, 2017
    Inventors: Koji Hayashi, James Matz, Satoshi Ishii, Yoshiaki Sekiguchi, Masamichi Kamiya
  • Patent number: 6489322
    Abstract: There are provided novel compounds of formula (I) wherein R1 represents a 2-thienyl or 3-thienyl ring and R2 represents hydrogen or C 1 to 4 alkyl and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are selective inhibitors of the neuronal isoform of nitric oxide synthase.
    Type: Grant
    Filed: May 21, 1998
    Date of Patent: December 3, 2002
    Assignee: AstraZeneca AB
    Inventors: James Macdonald, James Matz, William Shakespeare
  • Patent number: 6166030
    Abstract: There are provided novel compounds of formula (I) ##STR1## wherein R.sup.1 represents a 2-thienyl or 3-thienyl ring and R.sup.2 represents C 1 to 4 alkyl and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are selective inhibitors of the neuronal isoform of nitric oxide synthase.
    Type: Grant
    Filed: May 21, 1998
    Date of Patent: December 26, 2000
    Assignee: Astra Aktiebolag
    Inventors: James MacDonald, James Matz, William Shakespeare
  • Patent number: 6140322
    Abstract: There are provided novel compounds of formula (I) ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined in the specification and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: October 31, 2000
    Assignee: Astra Aktiebolag
    Inventors: James MacDonald, James Matz, William Shakespeare
  • Patent number: 5929085
    Abstract: There are provided novel compounds of formula (I) ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined in the specification and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy.
    Type: Grant
    Filed: January 22, 1997
    Date of Patent: July 27, 1999
    Assignee: Astra Aktiebolag
    Inventors: James MacDonald, James Matz, William Shakespeare
  • Patent number: 4695584
    Abstract: A method of producing synthetic brevicomin by direct distillation and a method of using the same in interfering with normal propagation of Dendroctonus beetles.
    Type: Grant
    Filed: January 24, 1983
    Date of Patent: September 22, 1987
    Assignee: University of Pittsburgh
    Inventors: Theodore Cohen, James Matz
  • Patent number: 4426535
    Abstract: A method of producing synthetic brevicomin by direct distillation and a method of using the same in interfering with normal propagation of Dendroctonus beetles.
    Type: Grant
    Filed: October 20, 1981
    Date of Patent: January 17, 1984
    Assignee: University of Pittsburgh
    Inventors: Theodore Cohen, James Matz